Medical interventions associated with HBV reactivation: Common and less common.
作者信息
Reynolds Justin A, Manch Richard A, Gish Robert G
机构信息
St. Joseph's Hospital and Medical Center, Center for Liver & Hepatobiliary Disease Phoenix AZ.
出版信息
Clin Liver Dis (Hoboken). 2015 Mar 27;5(2):32-34. doi: 10.1002/cld.413. eCollection 2015 Feb.
Abstract
摘要
相似文献
1
Medical interventions associated with HBV reactivation: Common and less common.与乙肝病毒再激活相关的医学干预措施：常见与不常见的。
Clin Liver Dis (Hoboken). 2015 Mar 27;5(2):32-34. doi: 10.1002/cld.413. eCollection 2015 Feb.
2
Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.术前 HBV-DNA 水平较低的乙型肝炎相关肝细胞癌患者，肝切除术后 HBV 再激活影响术后生存。
Ann Surg. 2013 Mar;257(3):490-505. doi: 10.1097/SLA.0b013e318262b218.
3
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.恩替卡韦与拉米夫定预防未治疗弥漫性大 B 细胞淋巴瘤接受 R-CHOP 化疗患者乙型肝炎病毒再激活：一项随机临床试验。
JAMA. 2014 Dec 17;312(23):2521-30. doi: 10.1001/jama.2014.15704.
4
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.HBsAg 阴性/抗-HBc 阳性的弥漫性大 B 细胞淋巴瘤患者化疗期间乙型肝炎病毒再激活发生率低：一项多中心回顾性研究。
Eur J Haematol. 2010 Sep;85(3):243-50. doi: 10.1111/j.1600-0609.2010.01474.x. Epub 2010 May 20.
5
Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.日本造血干细胞移植受者中乙型肝炎病毒再激活：核苷（酸）类似物预防和治疗的疗效
Int J Mol Sci. 2014 Nov 21;15(11):21455-67. doi: 10.3390/ijms151121455.
6
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.既往乙肝已缓解的淋巴瘤患者在接受含或不含利妥昔单抗的抗癌治疗过程中发生的乙肝病毒再激活。
J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.
7
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.接受细胞毒性化疗的乳腺癌患者中乙型肝炎病毒再激活：一项前瞻性研究。
J Med Virol. 2003 Aug;70(4):553-61. doi: 10.1002/jmv.10430.
8
Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.索磷布韦/维帕他韦成功治疗的HIV/HCV合并感染患者隐匿性HBV感染的再激活：一例病例报告及文献复习
BMC Infect Dis. 2017 Mar 1;17(1):182. doi: 10.1186/s12879-017-2287-y.
9
Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists.长期接受肿瘤坏死因子拮抗剂治疗的患者中乙型肝炎病毒再激活和肝毒性的发生率。
Clin Gastroenterol Hepatol. 2018 Dec;16(12):1964-1973.e1. doi: 10.1016/j.cgh.2018.04.033. Epub 2018 Apr 24.
10
A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy.恩替卡韦与拉米夫定预防实体瘤患者接受全身细胞毒性化疗时乙肝病毒再激活的比较
PLoS One. 2015 Jun 29;10(6):e0131545. doi: 10.1371/journal.pone.0131545. eCollection 2015.
引用本文的文献
1
Rheumatologists' awareness of hepatitis B reactivation before immunosuppressive therapy.风湿科医生在免疫抑制治疗前对乙型肝炎再激活的认识。
Rheumatol Int. 2019 Dec;39(12):2077-2085. doi: 10.1007/s00296-019-04437-y. Epub 2019 Sep 13.
2
Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians.乙型肝炎病毒在接受免疫抑制药物治疗的患者中的再激活：临床医生实用指南。
Clin Med (Lond). 2018 Jun;18(3):212-218. doi: 10.7861/clinmedicine.18-3-212.
3
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.免疫抑制治疗与乙型肝炎再激活风险：共识报告
Turk J Gastroenterol. 2018 May;29(3):259-269. doi: 10.5152/tjg.2018.18263.
4
Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations.免疫抑制患者中乙肝再激活的管理：当前推荐的最新进展。
World J Hepatol. 2016 Mar 18;8(8):385-94. doi: 10.4254/wjh.v8.i8.385.
本文引用的文献
1
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.利妥昔单抗治疗的 B 细胞淋巴瘤患者乙型肝炎病毒再激活：亚洲淋巴瘤研究组的分析。
Eur J Cancer. 2013 Nov;49(16):3486-96. doi: 10.1016/j.ejca.2013.07.006. Epub 2013 Aug 1.
2
Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases.接受肿瘤坏死因子（TNF）靶向治疗患者的乙型肝炎病毒（HBV）再激活：257例分析
Medicine (Baltimore). 2011 Nov;90(6):359-371. doi: 10.1097/MD.0b013e3182380a76.
3
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.利妥昔单抗相关的乙型肝炎病毒（HBV）再激活在淋巴增生性疾病中的作用：荟萃分析和 FDA 安全报告检查。
Ann Oncol. 2011 May;22(5):1170-1180. doi: 10.1093/annonc/mdq583. Epub 2010 Nov 29.
4
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.多柔比星洗脱微球栓塞治疗肝细胞癌的前瞻性随机研究：PRECISION V 研究结果。
Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52. doi: 10.1007/s00270-009-9711-7. Epub 2009 Nov 12.
5
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.既往乙肝已缓解的淋巴瘤患者在接受含或不含利妥昔单抗的抗癌治疗过程中发生的乙肝病毒再激活。
J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.
6
A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.接受经动脉化疗碘油栓塞术患者的先发拉米夫定随机对照研究。
Hepatology. 2006 Feb;43(2):233-40. doi: 10.1002/hep.21024.
7
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.对接受细胞毒性化疗的癌症患者中与乙型肝炎病毒（HBV）再激活相关的危险因素的综合分析。
Br J Cancer. 2004 Apr 5;90(7):1306-11. doi: 10.1038/sj.bjc.6601699.
8
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Hepatology. 2003 Jun;37(6):1320-8. doi: 10.1053/jhep.2003.50220.
9
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.泼尼松龙对乙肝表面抗原阳性慢性活动性肝炎的有害作用。
N Engl J Med. 1981 Feb 12;304(7):380-6. doi: 10.1056/NEJM198102123040702.
10
Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy.低剂量甲氨蝶呤治疗中断后乙肝病毒感染再激活导致的暴发性肝炎
Ann Intern Med. 1990 Mar 1;112(5):381-2. doi: 10.7326/0003-4819-112-5-381.
Zotero 插件